Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Biotechnology
UK-based drug discovery company Crescendo Biologics has hired Barbara Fleck as head of intellectual property.   2 February 2016
Generic Gleevec launches in US
Americas
India-based Sun Pharmaceutical has launched its generic version of Novartis’s cancer treatment drug Gleevec in the US.   2 February 2016
Federal Circuit affirms invalidation of two Illumina patents
Americas
The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.   1 February 2016
Americas
The Patent Trial and Appeal Board has rejected generics company Lannett Holdings’s petition for an inter partes review because it was filed one day too late.   29 January 2016
Americas
PDL BioPharma has sued Merck Sharp & Dohme in a complaint that centres on a now-expired patent directed to treating melanoma.   28 January 2016
Americas
Medical devices maker Greatbatch has secured a $37.5 million patent victory at a US court.   27 January 2016
Americas
US law firm Wolf Greenfield has promoted Jenny Chen, Thomas Franklin and Jessamine Lee to shareholders.   27 January 2016
Americas
Law firm Lerner David Littenberg Krumholz & Mentlik has hired Tedd Van Buskirk as partner in its intellectual property practice in Westfield, New Jersey.   26 January 2016
Africa
Pharmaceutical companies including Cipla and Natco Pharma have signed a sub-licensing deal enabling them to produce a generic version of Bristol Myers Squibb’s hepatitis C drug Daclatasvir.   26 January 2016
Americas
The US Court of Appeals for the Federal Circuit has rejected Pfizer’s plea to extend the term of a patent centring on cancer treatment, upholding a lower court’s ruling that cleared the US Patent and Trademark Office of wrongdoing.   25 January 2016